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Abstract.  Mitogen-activated protein kinases (p42  '~'k 
and p44  "~k) are serine/threonine  kinases that are acti- 
vated rapidly in cells stimulated with various extracel- 
lular signals.  This activation is mediated via MAP ki- 
nase kinase (p45-~-t), a dual specificity kinase which 
phosphorylates two key regulatory threonine and tyro- 
sine residues of MAP kinases.  We reported previously 
that the persistent phase of MAP kinase activation is 
essential for mitogenically stimulated cells to pass the 
"restriction point" of the cell cycle. Here, using specific 
polyclonal antibodies and transfection of epitope- 
tagged recombinant MAP kinases we demonstrate that 
these signaling protein kinases undergo distinct spatio- 
temporal localization in growth factor-stimulated cells. 
In G0-arrested hamster fibroblasts the activator 
p45  m~ and MAP kinases (p42  "~pk, p44  m~) are mainly 
cytoplasmic. Subsequent to mitogenic stimulation by 
serum or o~-thrombin both MAP kinase isoforms trans- 
locate into the nucleus.  This translocation is rapid 
(seen in  15 min),  persistent (at least during the entire 
G1 period up to 6 h),  reversible (by removal of the 
mitogenic stimulus) and apparently 'coupled' to the 
mitogenic potential;  it does not occur in response to 
nonmitogenic agents such as a-thrombin-receptor  syn- 
thetic peptides and phorbol esters that fail to activate 
MAP kinases persistently. When p42  m~ and p44-~,k 
are expressed stably at high levels, they are found in 
the nucleus of resting cells; this nuclear localization is 
also apparent with kinase-deficient mutants (p44,~,k 
T192A or Y194F).  In marked contrast the p45  "~pa ac- 
tivator remains cytoplasmic even during prolonged 
growth factor stimulation and even after high expres- 
sion levels achieved by transfection.  We propose that 
the rapid and persistent nuclear transfer of p42  "~k and 
IM4  "~ during the entire G0-G1 period is crucial for 
the function of these kinases in mediating the growth 
response. 
T 
HE sequence of events which link cell surface recep- 
tor-mediated signals to expression of a specific pattern 
of genes has received considerable attention  in recent 
years. Although many gaps remain to be filled, the remark- 
able degree of homology that is emerging between yeast and 
mammalian  signaling pathways should help in elucidating all 
sequential  events. In particular,  the linear cascade of yeast 
protein  kinases:  byr2  (stell)--'byrl  (ste7)--'spkl  (FUS3/ 
KSS1),  linking  pheromone  receptor  to  gene  expression 
(Nielsen, 1993) is amazingly  well conserved in mammalian 
cells.  The corresponding mammalian "signaling module" is 
mitogen-activated  protein  (MAP)  ~ kinase  kinase  kinase 
(MAPKKK)----MAP  kinase  kinase  (MAPKK)~MAP  ki- 
nases (MAPK) (Lange-Carter et al.,  1993; Neiman et al., 
1993).  MAP kinases,  also described as extracellular-regu- 
lated kinases (ERK), belong to a family of serine/threonine 
protein kinases (Sturgill and Wu, 1991; Boulton et al., 1991; 
1.  Abbreviations  used  in  this  paper:  aa,  amino  acid;  MAP,  mitogen- 
activated protein. 
Pelech et al.,  1992) that have been shown to participate  in 
signaling  pathways initiated  by mitogens or differentiating 
agents. In mammalian  cells there are at least two highly ho- 
mologous MAP kinases:  p42~  or ERK2 and p44  ~'~ or 
ERKI (Boulton et al., 1991). They share the same substrates 
in vitro (Sturgill et al.,  1988; Pulverer et al.,  1991; North- 
wood et al.,  1991; Alvarez et al.,  1991; Gille et al.,  1992) 
and  the  same time course of activation  (Meloche et al., 
1992a).  They are expressed ubiquitously (Boulton et al., 
1991) and closely related to the yeast protein kinases  in- 
volved in pheromone-induced mating:  SLT2 (Torres et al., 
1991), KSS1 (Courchesne et al., 1989), and FUS3 (Elion et 
al.,  1990) in budding yeast and spkl (Toda et al.,  1991) in 
fission  yeast.  This  homology of sequence also  reflects  a 
similarity  in function since spkl defect of S. pombe can be 
complemented by expressing  either rat p42  ~.k (Neiman  et 
al.,  1993) or hamster p44~  (Nielsen, O.,  and J.  Pouys- 
s6gur, unpublished results). 
In fibroblasts,  MAP kinases undergo a rapid and biphasic 
activation  in  response  to  all  mitogens  (Meloche  et  al., 
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threonine and tyrosine residues (Ray and Sturgill, 1988; An- 
derson et al.,  1990) by a dual specificity kinase of 45 kD 
termed  the  MAP  kinase  activator  or  MAP kinase  kinase 
(p45m~  a) (Ahn et al.,  1990; Nakielny et al.,  1992; Seger et 
al.,  1992;  Roberts,  1993;  Kosako et al.,  1993).  In  turn, 
p45 "~pa is activated by phosphorylation of serine/threonine 
residues (Kosako et al.,  1992) and corresponds to the yeast 
homologs  byrl/ste7.  One  potential  upstream  activator  of 
p45  ~pa is the proto-oncogene c-raf, since immunoprecipi- 
tated v-rafand activated c-rafcan re-activate dephosphory- 
lated  p45  ~'a  (Kyriakis  et  al.,  1992;  Dent  et  al.,  1992; 
Howe et al.,  1992). Most interesting, however, is the recent 
discovery of another mammalian  activator of MAP kinase 
kinase; it is a serine/threonine  kinase of 78 kD, also regu- 
lated by phosphorylation, and found to be analogous to the 
yeast byr2/ste11  (Lunge-Carter et al.,  1993). 
We have shown previously that MAP kinases are essential 
for GO to S-phase transition in fibroblasts. First, we showed 
that the growth factor-induced second and persistent phase 
of MAP  kinase  activation  correlates  with  the  mitogenic 
potential of the stimulus (Meloche et al.,  1992a) and second 
that inhibition of both MAP kinases by expression of either 
a p44  m~pk antisense cDNA or dominant-negative allele sup- 
presses cell growth (PagEs et al., 1993). Here, using indirect 
immunofluorescence microscopy, we demonstrate that both 
p42  m~ and p44  m~pk rapidly  and persistently  translocate  to 
the nucleus in response to strong  mitogens whereas their 
common  activator,  p45  ~pa,  remains  cytoplasmic.  This 
finding supports the notion that these kinases play a critical 
role in relaying surface receptor-mediated signals to the nu- 
cleus. 
Materials and Methods 
Materials 
Highly purified human a-thrombin and basic FGF were generous gifts of 
Drs. J. W. Fenton II (New York State Department of Health, Albany, NY) 
and D. Gospodarowicz (University of  California Medical Center, San Fran- 
cisco,  CA),  respectively.  BSA  (fraction  V)  was  obtained  from  Sigma 
Immunochemicals  (St  Louis,  MO).  Synthetic  peptides  C17p44  (CIF- 
QETARFQPGAPEAP)  corresponding  to  the  rat  p44  mapk 16  carboxyl- 
terminal  amino  acid  (aa) and  the synthetic peptide  C15p42 (CIFEET- 
ARFQPGTRS) corresponding to the rat p42  ma~t 14 carboxyl-terminal aa 
were both synthesized with a Cysteine at the amino terminus by Dr.  G. 
Drapeau (Universit~ Lavai, Qutbec, Canada). The rabbit polyclonal antise- 
rum  837  (Boulton et al.,  1991) was kindly  provided by  Dr.  M.  Cobb 
(University of  Texas Southwestern Graduate school of  Biomedical Sciences, 
Dallas,  TX)  which  was  raised  against  the  synthetic  peptide  0FQ- 
ETARFQPGAPEAP)  corresponding  to  the  rat  p44  "~pk  16  carboxyl- 
terminal aa. Fluorescein-conjugated anti-rabbit and anti-mouse IgG from 
sheep were obtained from Amersham (UK). A synthetic peptide N16p45 
(PKKKPTPIQLNPNPEY)  corresponding  to the Xenopus /aev/s p45  ''~'a 
16 amino-terminal aa and synthetic hamster ct-thrombin receptor peptide 
(7-mer  =  SFFLRNP)  were  synthesized by  Neosystem SA (Strasbourg, 
France).  mAb  P4D5 which  recognizes  the  epitope  YTDIEMNRLGK 
(VSVG; Kreis, 1986) was kindly provided by Dr. B. Goud (Institut Pasteur, 
Pads, France). A mouse p42  "~'~ eDNA clone (pBA4) was kindly provided 
by Prof.  M. Weber (University of Virginia, Charlottesville, VA). 
Cell Line and Cell Culture 
The Chinese hamster lung flbroblast cell line CCL39 (ATCC) and its deriva- 
tive TR4-44" overexpressing an epitope-tagged p44  "~  (Meloche et al., 
1992a,b) were cultured in DMEM (GIBCO BRL, Gaithersburg, MD) sup- 
plemented with 7.5% FCS and antibiotics (50 U/ml penicillin and 50/~g/ml 
streptomycin) at 37°C in an atmosphere of 95% air, 5% CO:. Quiescent 
cells  (GO-arrested) were  obtained  by  incubating  confluent  cultures  in 
serum-free medium for 24-48 h. Cells were then treated with various agents 
as described in Results and figure legends. 
Western Blot Analysis 
Confluent cells were lysed in Triton X-100 lysis buffer (0.2% Triton X-100, 
50 mM Tris-HCl,  pH 7.5, 5 mM EDTA, 1 mM PMSE 1 mM iodoacet- 
amide, I mM o-phenanthroline). 25/zg of  detergent-extracted proteins were 
separated by SDS-PAGE on 10% (wt/vol) polyacrylamide gel (29:1), elec- 
trophoreticaily transferred to Hybond-C membranes (Amersham, UK) and 
immuno-probed as described previously (Meloche et al.,  1992a). 
Immunoprecipitation of  p44  '~pk and MBP Kinase Assay 
The kinase activity was measured in presence of 25/~M of nonradioactive 
ATP and 3 #Ci of 732p-ATP per assay for 15 min at 30°C, essentially as 
described previously by Meloche et al. (1992a) except that 1/~l of 837p an- 
tiserum was added per assay (one well of a 12-well plate). Each assay was 
normalized per 1 /~g of protein present in cell lysates. 
Indirect Immunofluorescence Microscopy 
GO-arrested or  serum-stimulated  CCL39  cells  and  transfectants  were 
washed with PBS and fixed at  -20°C for 10 rain with methanol/acetone 
(3:7, vol/vol). After a  10-rain rehydration at 25°C in PBS containing 3% 
BSA (PBS/BSA), fixed cells were then incubated with the primary antibody 
for 60 rain at 25°C. Cells were then washed five times with PBS and in- 
cubated in PBS/BSA for 60 min at 25°C with fluorescein-conjugated sec- 
ondary  antibody  (anti-mouse  or anti-rabbit,  1:50). Finally, cells  were 
washed five times with PBS and examined under epifluorescent illumination 
with excitation-emission filters for fluorescein. To control for specificity; 
(a) the same results were obtained when cells were fixed with 1% parafor- 
maldehyde in methanol at -20°C for 15 rain or with 4% paraformaldehyde 
in PBS at 20°C for 15 rain followed by permeabilization with 0.2% Triton 
X-100 in PBS for 5 min at 20°C (data not shown); (b) incubation with sec- 
ondary antibody alone did not reveal any significative fluorescent signal 
(data not shown). 
Immunopurification  of  Antibody MKKI6 
Antiserum MKK16 was obtained from a rabbit injected with the N16p45 
peptide  coupled  to  KLH  (keyhole limpet  hemocyanin).  The  antiserum 
MKK16 was either used directly (1:2,000) or immunopurified as follows: 
100 #1 of  pre-immune and MKK16 antisera were incubated overnight at 4°C 
with 25/zg of  peptide N161M5 coupled to KLH, bound to Hybond C-super 
membranes (Amersham, UK). After five washes with TN buffer (50 mM 
TrisCl,  150 mM NaC1, pH 8.0), antibody bound to the membrane  was 
eluted for 30 min at 20°C with 100/d of the "ImmunoPure gentle Ag/Ab 
elution buffer" from Pierce (Rockford, IL). This solution was then dialyzed 
on Millipore filters (type VSWPff2500) against TN buffer for 2 h at 4°C. 
Immunofluorescence microscopy was then performed as described above, 
except that PBS was replaced by TN buffer. Similar results were obtained 
with antibody MKK16-b, obtained from another rabbit (data not shown). 
DNA Constructs and Expression Vectors 
EcoRV restriction sites were introduced in the terminal stop codons of  both 
p44  mapk (Meloche et al., 1992a) and p42  mapk (L'Allemain et al., 1992a), by 
the method of Kunkel (Bio Pad mutagenizing kit; BioRad Labs, Hercules, 
CA) to add the sequence WEGPPGP-YTDIEMNRLGK  (hinge-VSVG epi- 
tope; Kreis, 1986). These epitope-tagged MAP kinases were subcloned in 
the expression vector pcDNA-nco. The amino acid substitutions presented 
in the results section at positions 192 and 194 were introduced in the Chi- 
nese hamster p44  "~  cDNA by the method of Kunkel. p44  mapk'vsvG 4239 
was obtained by creating an EcoRV site at the residue 239 and adding the 
P4D5 epitope recognition sequence at this position, thus deleting 129 aa's 
out of the 369 aa's of Chinese hamster p44  mapk (truncation of 30%). 
Results 
Specificity of the p44~pk Antiserum 837 
Rabbit  antiserum  837  (Boulton  et  al.,  1991)  was  raised 
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strating  specificity of antise- 
rum 837 for p44  ma~. Antise- 
rum 837 was used to detect 
p44  ~'k  (p44)  in  25  ~tg  of 
detergent-extracted  proteins 
from Chinese hamster lung fibroblasts CCL39 0aries 1) and from 
a CCL39 transfectant (TR4-44") overexpressing an epitope-tagged 
p44  '~  (p44") (lanes 2).  The  antiserum  837  was  used  either 
directly (1:1,500) (A), or after blocking with IM2-antigenic  peptide 
C15p42 (150 /zg/ml with  180 min preincubation)  (B),  or after 
blocking with C15p42 (150/~g/ml) and the p44 antigenic peptide 
C17p44 (450/zg/ml)  (C). 
against  a  17-aa  synthetic  peptide  corresponding  to  the 
predicted carboxy terminus  of p44  '~pk. Its  specificity was 
tested by immunobloting (Fig.  1 A) total cell lysates of both 
CCL39 fibroblasts and of TR4-44" cells, a CCL39 transfec- 
tant  overexpressing  an  epitope-tagged  p44  MAP  kinase 
(p44  *~pk) (Meloche et al.,  1992b).  837  antiserum recog- 
nizes predominantly p44"~p  k (44 kD) and p44  *~'pk but also 
weakly p42  m~ (Fig.  1 A).  However, this antibody became 
monospecific for p44  ma~ after preincubation with a  15-aa 
synthetic peptide corresponding to the carboxy terminus of 
the p42 MAP klnase (antiserum 837p, Fig. 1 B). This proce- 
dure was used for the immunolocalization of p44  ma~. The 
specific recognition of p44  mapk and p44  *m~pk was blocked by 
pre-incubation with the p44 antigenic peptide (Fig.  1 C). 
Immunolocalization of  MAP Kinases in Resting and 
Serum-stimulated CCL39 Fibroblasts 
Immunofluorescence microscopy was performed with 837p 
antiserum  on  GO-arrested  and  serum-stimulated  CCL39 
cells. To ensure that the staining observed was specifc, sev- 
eral  different  fixation-permeabilization  procedures  were 
used for sample preparation (methanol/acetone, 4 % parafor- 
maldehyde, methanol/paraformaldehyde), and in each case 
it was ensured that the signal obtained could be extinguished 
by pre-incubation of diluted antisera with the corresponding 
antigenic p44 peptide or both the p44 and p42 antigenic pep- 
tides as shown in Fig. 2 E  As illustrated in Fig. 2, the ob- 
served staining  for p44  ~apk shows  first that in GO-arrested 
CCL39 cells, p44m~k-immunolabeling  was cytoplasmic and 
a  diffuse staining suggested no association with any orga- 
nized cellular structure (Fig. 2 A). Second, as judged by im- 
munofluorescence microscopy,  p44  "~k underwent  a  com- 
plete  redistribution  in  serum-stimulated  cells,  starting  to 
move to the nucleus as early as 15 min (Fig. 2 B) and becom- 
ing  predominantly nuclear  1-3  h  after serum-stimulation 
(Fig. 2,  C and D). However, this nuclear translocation was 
transient, p44  "~pk starting to return to the cytoplasm 6 h af- 
ter serum stimulation (data not shown), to be again totally 
cytoplasmic between 6 and 9 h after serum stimulation (data 
not shown). This timing suggests that p44  map* nuclear trans- 
location is a GO to S-phase transition-specific event. The nu- 
clear efflux of p44  m~k can also be triggered by removal of 
serum  1 h  after stimulation.  Exit of p44  m~ from the nu- 
cleus is partial 30 min after serum removal (compare Fig. 
2,  C  and E)  and complete at  1 h  (data not shown).  This 
demonstrates that continuous serum stimulation of cells is 
necessary to maintain p44  m~pk in the nucleus, at least during 
the initial period of stimulation. 
MAP Kinase Remains Active during the Period of 
Nuclear Localization 
As illustrated in Fig. 3, MAP kinase activity immunoprecipi- 
tared by 837p antiserum, was measured by phosphorylation 
of MBP  in  serum-starved  and  serum-stimulated  CCL39 
fibroblasts  (by  10%  FCS).  As  previously  described  for 
CCL39 cells (Meloche et al., 1992a; Kahan et al., 1992) the 
activation of endogenous p44~  is biphasic in response to 
potent mitogens such as 10% serum or ot-thrombin; a rapid 
activation occurring between 5 and 10 min after agonist addi- 
tion is followed by a second broad wave of activation lasting 
at least 3 h. We show here that this second peak of activity 
decreased thereafter continuously from 3 to 9 h after serum 
stimulation. However, it never returned to the basal level ob- 
served in GO-arrested cells (four out of five trials) indicating 
that MAP kinase activity is still elevated over basal levels at 
times when nuclear localization of this  kinase is  still ob- 
served (Figs. 2 and 3). Thus, after translocation to the nu- 
cleus, part of the active MAP kinase pool could phosphory- 
late  several of its  in  vitro substrates  such as  the  nuclear 
proteins c-jun (Pulverer et al.,  1991;  Baker et al.,  1992), 
c-myc (Alvarez et al.,  1991) and p62  rcF (Gille et al.,  1992). 
Note that removal of serum growth factor induced a  rapid 
deactivation of MAP kinase concomitant with its disappear- 
ance from the nucleus. 
The Potency of Growth Promoting Agents to Induce 
MAP Kinase Nuclear Translocation  Correlates  with 
Their Relative Potency to Promote S-phase Entry 
We have shown in this laboratory that the sustained second 
phase of p44"~ kinase activation correlates with mitoge- 
nicity since it is observed in cells stimulated with mitogenic 
agents such as oe-thrombin  or FGF but not after stimulation 
by  non-mitogenic  agents  such  as  carbachol  (Pouysstgur 
and Seuwen,  1992; Kahan et al.,  1992), phorbol esters or 
c~-thrombin  receptor peptide (Vouret et al.,  1993).  Fig.  4 
shows  that  a  similar  correlation  was  observed  for  the 
p44~  nuclear translocation; potent mitogens induced nu- 
clear translocation whereas weak or co-mitogens did not. 
For example, treatment of GO-arrested cells CCL39 cells for 
3 h with non-mitogenic stimuli, such as phorbol esters (data 
not shown) or ot-thrombin receptor peptide (Fig. 4 B) failed 
to induce IM4m~ nuclear translocation. In contrast, growth 
factors such  as  c~-thrombin  (Fig.  4  A)  or FGF  (data  not 
shown) were able to promote GO/G1 p44~  nuclear trans- 
location.  Although  these  mitogens  were less  potent than 
10%  serum in their ability to trigger IM4  '~pk nuclear trans- 
location when added individually, they became equivalent to 
serum when added together (ot-thrombin/FGE Fig. 4 C). In- 
terestingly, the intensity and percentage of nuclei harboring 
p44  "~ immunolabeling seemed to correlate well with the 
relative potency of  these mitogens to re-initiate DNA synthe- 
sis  (Fig. 4) (Vouret-Craviari et al.,  1992). 
Immunolocalization of  p42m~ Isoform in 
CCL39 l~broblasts 
Our attempts to obtain antisera that exclusively recognised 
p42  m~  in  immunoblotting were unsuccessful;  all  antisera 
tested presented some reactivity against p44  "~pk. 
Thus, we resorted to transfecting epitope-tagged isoforms 
to study their specific subcellular localization. We added 18 
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fluorescence microscopy show- 
ing p44  "~ nuclear transloca- 
tion after serum stimulation of 
G0-arrested  cells.  CCL39 
fibroblasts  were incubated  in 
serum-free  medium  for  2  d 
(G0-arrested)  (A)  and  then 
were stimulated  by the addi- 
tion  of  10%  FCS  for  15 
(B), 60 (C) or 180 (D and G) 
rain.  Similarly,  Go-arrested 
TR4-44"  cells  were  stimu- 
lated  for  180 min with  10% 
serum (H).  In E, cells  were 
stimulated  with 10% FCS for 
60  min,  washed  thoroughly 
and  incubated  in  serum-free 
medium  for  30  min  before 
fixation.  Cell fixation and im- 
munofluorescence  labeling 
procedures were performed as 
described  in  Materials  and 
Methods.  The  first  antibody 
was the 837 antiserum (1:400) 
blocked  with  C15p42  (150 
/~g/ml)  (A-E)  or  blocked 
simultaneously with peptides 
C15p42  (150  /zg/ml)  and 
C17p44 (450/~g/ml)  (F). The 
difference  in  p44  specific 
fluorescence labeling between 
CCL39  cells  and  TR4-44" 
cells was demonstrated using 
a  higher dilution (1:1,000) of 
the  837  antiserum  (compare 
panels G and H). Cells were 
obtained  with  a  Nikon  Di- 
aphot  microscope,  objectif 
fluor 40,  1.3 oil. Bar,  10/zm. 
aa's corresponding to the epitope  recognized by the  mAb 
VSVG and a hinge region (Kreis,  1986) at the carboxy termi- 
nus  of the two  MAP kinases  isoforms;  these  proteins  are 
termed  p42  "~*-vsv° and  p44  "~p~-vsvG. As  shown  in  Fig.  5, 
serum-stimulated CCL39 cells expressing either p44  "~-vsv° 
(Fig.  5  A)  or p42  "~o*-vsvG (Fig.  5  B)  showed  specific  im- 
munolabeling located mostly in the nucleus with the exclu- 
sion of nucleoli (observed with the VSVG epitope-specific 
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Figure 3. Time course ofMBP kinase activation in response to 10% 
FCS. MBP kinase activity was measured and normalized as de- 
scribed in Materials and Methods. Confluent CCL39 cells (12-well 
plates)  were serum deprived for 24 h, stimulated  with 10%  FCS 
and then harvested either 1, 3, 6, or 9 h after stimulation  (+FCS). 
Alternatively,  cells were stimulated  for 1 h, and then washed three 
times with serum-free medium and harvested 30 min or 3 h later 
(Wo FCS).  The data presented are representative  of five experi- 
ments which gave similar results. 
mAb P4D5, see Materials and Methods). In both cases (Fig. 
5, A and B) nonexpressing cells showed a weak background 
staining  notably excluded from the  nucleus.  The VSVG- 
specific staining was observed with cells fixed either with 
4% paraforamaldehyde and permeabilized with 0.2% Triton 
X-100 or for cells fixed with methanol/acetone (30:70%) at 
-20°C  (Materials  and  Methods).  Furthermore,  no  im- 
munofluorescent signal was detected in cells transfected with 
p44,~-(~vs~)  harboring  a  truncated  VSVG  epitope  (data 
not shown). From these experiments, we conclude that trans- 
fected proteins p42~ -vsv° and p44  "~-vsw are located in the 
nucleus of serum-stimulated  CCL39 cells. 
It is important to note that the expression level of  each full- 
length transfected isoform (WT-p42"~, p44  "~,  p42~ -vsw, 
and  p44  "~,*-vsvG) altered  their  subcellular  localization  in 
serum-starved cells, a high level of expression induced a par- 
tial nuclear localization in serum-starved cells. Cytoplasmic 
MAP kinase  localization  in  serum-deprived  cells  and nu- 
clear translocation  to the  nulceus  after  serum  stimulation 
was observed only in transfectants expressing low levels of 
this protein (data not shown). 
Figure 4.  Immunofluorescence labeling 
of p44  "~  showing  a  correlation  be- 
tween mitogenicity and nuclear translo- 
cation.  G0-arrested  CCL39 fibroblasts 
were  stimulated  for  180  min  with  10 
U/ml  a-thrombin  (A),  100  #g/ml  of 
7-mer  synthetic  a-thrombin  receptor 
peptide (B), or simultaneously with 10 
U/ml  tx-thrombin  and  25  ng/ml  FGF 
(C). Immunofluorescence labeling  pro- 
cedures were performed as described in 
Materials  and Methods with antiserum 
837p (1:400). Solid black bars represent 
the  reimtiation  of DNA  synthesis  ex- 
pressed as the percent of the maximal 
[~H]thymidine  incorporation  obtained 
with  10%  FCS measured after 24 h as 
described previously (Vouret-Craviari et 
al.,  1992).  Bar,  10 #m. Figure 5. Indirect immunofluorescence microscopy of CCL39 cells expressing epitope-tagged MAP kinases. Immunofluoreseence labeling 
procedures of  epitope-tagged MAP kinases were performed as described in Materials and Methods with the P5D4 mAb as primary antibody 
(1:500) and anti-mouse IgG coupled to fluorescein as secondary antibody (1:50). Serum-stimulated CCL39 cells expressing the following 
epitope-tagged MAP kinases constructs are presented: (A) p44  '~'vsw, (B) 1M2  "~vsvG, (C) p44  "~svG T192A, (D) p44  ~vsw  TI92E- 
Y194E, and (E) p44  mapk'vsvG-a239. Cells were observed with a Nikon Diaphot microscope,  objective ttuor  100, 1.3 oil. Bar,  10 ~tm. 
We conclude that both p42  "~-vsv~ and p44,~-vsv~ trans- 
locate to the nucleus after growth factor stimulation, how- 
ever when highly expressed their location is both cytoplas- 
mic and nuclear in serum-starved cells. 
Figure  6.  Western  blot 
demonstrating  specificity  of 
MKK16 antiserum for p45  "O*. 
MKK16 antiserum  was  used 
to detect p45  ~'~ (p45) in de- 
tergent-extracted proteins from 
CCL39 fibroblasts (lanes 1, 2, 
and  3)  and  of  the  CCL39 
transfectant  (CCL39-p45) 
overexpressing  an  epitope- 
tagged p45  ''~k (p45") (lanes 
4 and 5). Each lane contained 
25  ttg  of detergent-extracted 
proteins.  The  Western  blots 
were probed with pre-immune 
serum  (lane  /),  antiserum 
MKK16 at 1:2,000 dilution (lanes 2 and 4), and MKK16 (1:2,000) 
blocked with  10/tg/ml MKK16-antigenic peptide N16p45 prein- 
cubated for 30 min at 37°C (lanes 3 and 5). 
MAP Kinase Nuclear Localization Occurs with 
Kinase-dead Mutants 
MAP kinase activation results from phosphorylation of T192 
and Y194 residues by the activator p45"~  *k. We and others 
have shown that mutations of either of these phosphorylation 
sites totally inactivate MAP kinases  (Posada and  Cooper, 
1992;  L'Allemain et al.,  1992b;  Pages et al.,  1993).  We 
decided to test whether the activation of MAP kinases by 
phosphorylation  was  necessary  for  nuclear  translocation. 
Thus,  by  site-directed  mutagenesis  of p44~ -vsw  we  re- 
moved the  key phosphorylation  sites  (T192A,  Y194F)  or 
substituted  them  by  negatively  charged  residues  (T192E, 
Y194E).  Different  combinations  of these  mutations  were 
tested in stable transfected clones.  As shown in Fig.  5  the 
TI92A (Fig.  5  C) and T192E-Y194E  (Fig.  5 D) mutations 
that abolish MAP kinase activity did not alter the nuclear 
translocation.  Subcellular  localization  of  these  mutants, 
including  Y194F,  T194E,  and  Y194E  (data  not  shown) 
was  indistinguishable  from  that  of transfected  wild  type 
p44~ -vsv° (Fig. 5 A). In addition,  serum-induced nuclear 
translocation of these mutants can be detected in cells with 
low expression levels. 
The Journal  of Cell Biology,  Volume 122, 1993  1084 Figure 7.  Indirect immunofluorescence  microscopy of the MAP kinase activator, p45  ~eu. Immunofluorescence  labeling procedures of 
p45  m°pk~ were performed as described in Materials and Methods with CCL39 cells (A-D) and p45  "~a transfected-CCL39 cells (E). G0- 
arrested CCL39 fibroblasts (A) were stimulated with 10% FCS (B-E). The primary antibodies were immunopurified MKK16 antibody 
(1:50) (A and B); immunopurified MKK16 (1:50) blocked for 30 min at 37°C with the antigenic peptide N16p45 (10 #g/ml) (C); im- 
munopurified pre-immune MKK antibody (1:50) (D); and antibody MKK16 (1:2,000) (E). Bar, 10/zm. 
We conclude that the transfer and the retention of MAP ki- 
nases in the nucleus is independent of the state of MAP ki- 
nase activity. 
Characterization of  p45  m~a Antibody 
As shown on Fig. 6, lane 3, rabbit-antiserum MKK16 raised 
against the NH2-terminal peptide of Xenopus MAP kinase 
kinase  (peptide  N16p45,  see  Material  and  Methods), 
specifically recognized a single band with an apparent mass 
of,o45 kD on immunoblots prepared from cytosolic extracts 
of  CCL39  cells.  Pre-immune  antiserum  and  MKK16- 
antiserum blocked with the antigenic peptide N16p45  failed 
to display any specific labeling (Fig. 6, lanes 1 and 2, respec- 
tively). In addition, MKK16 antiserum recognized recom- 
binant IM5  mapa* stably transfected in CCL39 cells (Fig.  6, 
lane  4).  The  specific  recognition  of  p45  "~*  was  also 
blocked by pre-incubation of MKK16-antiserum with the an- 
tigenic peptide N16p45  (Fig. 6, lane 5).  p45  '~pa" displayed 
a retarded migration in SDS-PAGE due to the addition of the 
HA1 epitope at the amino terminus of the Chinese hamster 
p45"~a-cDNA  (Pages,  G.,  A.  Brunet,  G.  L'Allemain, P. 
Lenormand, and J. Pouyss6gur, manuscript in preparation). 
Another rabbit antiserum (MKK16-b) raised independently 
against the same peptide N16p45, displayed similar specific- 
ity and immunoreactivity (data not shown). 
Furthermore, these antisera immunoprecipitated a protein 
kinase from CCL39 cytosolic extracts able to tyrosine-phos- 
phorylate  and  re-activate  recombinant  inactive  p42"~  k. 
These data confirm the immunoreactivity of these antisera 
with the mammalian MAP kinase activator p45~p a  (Pages, 
G., A. Brunet, G. L'Allemain, P. Lenormand, and J. Pouys- 
s6gur,  manuscript in preparation). 
Cellular Immunolocalization of the MAP Kinase 
Activator  p4  5m~pa 
Using  indirect-immunofluorescence microscopy  with  im- 
munopurified MKK16 antiserum,  we localized p45~  in 
the cytoplasm of serum-starved CCL39 cells with no appar- 
ent association with organized cellular structure (Fig. 7 A). 
After 3 h of serum stimulation, p45  ~a  was still cytoplas- 
mic (Fig. 7 B). In fact iM5m'p  a remained in the cytoplasm of 
exponentially growing CCL39 cells (data not shown) and 
even when it was overexpressed (Fig. 7 E). This cytoplasmic 
localization was also observed in other fibroblastic and epi- 
thelial  cell  lines  (Swiss  3T3,  COS  7,  MDCK,  data  not 
shown). To ensure that the observed staining was specific, 
two  fixation-permeabilization procedures  were  used  for 
sample  preparation:  methanol/acetone (30:70%)  and 4% 
paraformaldehyde/0.2  % Triton X-100, and in each case we 
demonstrated that the signal could be extinguished by pre- 
Lenormand  et al. Immunolocalization of MAP Kinase and Its Activator  1085 Figure 8. Confocal laser scan- 
ning  microscopy  of p45  ~'~a 
and p44  ~'~.  Immunofluores- 
cence  labeling  procedures 
were performed as described 
in  Materials  and  Methods 
with  CCL39  cells,  serum- 
starved for 24 h (-FCS) or the 
same  cells  after  stimulation 
with  20%  FCS  for  3  h 
(+FCS).  The  antisera  837p 
(1:500) and MKK16 (1:1,000) 
were used for immunodetec- 
tion of IM4  '~  and p45  ~a, 
respectively. Optical sections 
in the  center  of nuclei were 
performed at 2.1/zm from the 
bottom  of the  cells  using  a 
Leica  confocal  microscope. 
Bar, 5 ~m. 
incubation of  diluted antisera with the antigenic peptide (Fig. 
7  C)  and  strongly increased after transfection of 1M5~ 
cDNA (Fig. 7 E). Immunopurified pre-immune sera from 
the same rabbit did not display any specific immunoreac- 
tivity (Fig. 7 D). 
Confocal laser  scanning  microscopy was  performed to 
confirm the absence of p45  "~pa in the nucleus. Optical sec- 
tions passing through the center of nuclei were obtained with 
CCL39 cells labeled either with antisera MKK16 antisera to 
detect t>45  m~pa, or  antisera  837p  to  detect p44  m~pk. These 
data, presented in Fig.  8 demonstrate the total absence of 
p45~  in the nucleus of both serum-stimulated and non- 
stimulated  CCL39  ceils.  This  situation  sharply  contrasts 
with  the  redistribution of p44~  in  the  same  cells upon 
stimulation with serum. 
We conclude that  although both MAP  kinase  isoforms 
translocate to the nucleus after growth factor stimulation, 
their upstream activator p45  ~-~ remains strictly cytoplas- 
mic during the cell cycle. 
Discussion 
In this study, we were able to examine specifically the subcel- 
lular localization of endogenous p44  ~pk. Clearly, endoge- 
nous p44  ~k translocated to the nucleus after growth factor 
stimulation of G0-arrested CCL39 cells. The time course of 
p44~p  k translocation to the nucleus indicated that p44  ~apk 
was present in the nucleus soon after stimulation (at least 15 
min), and remained nuclear up to 6  h  after growth factor 
stimulation. This process parallels the long lasting phase of 
MAP kinase activation. Interestingly, growth factor removal 
rapidly reverses the process of p44  "~pk nuclearization and 
abolishes its activation. It is thus very likely that p44,~k is 
indeed active when it appears in the nucleus after growth fac- 
tor stimulation. Using an epitope-tagging strategy, we were 
able to demonstrate that transfected p42  "~ also is nuclear 
upon growth factor stimulation.  The same conclusion was 
reached  when  p44  ~pk  and  p42  ma~  were  analyzed  in  rat 
mesangial cells stimulated with either serum or endothelin 
(Wang,  Y.,  J.  Pouyss6gur,  and  M.  Dunn,  unpublished 
results).  Hence,  we  must  conclude that  both p42  "~pk and 
p44~  which  share high homology, a  common activator 
and identical in vitro substrate, both translocate to the nu- 
cleus. This implies that some of  the known in vitro substrates 
of MAP kinases,  such as the nuclear transcription factors 
c-jun (Pulverer et al.,  1991; Baker et al.,  1992), c-myc (A1- 
varez et al.,  1991),  and p62  rcF (Gille et al.,  1992) can also 
be phosphorylated in vivo by MAP kinases.  Our findings 
confirm and extend the previous report of Chen et al. (1992) 
on nuclear translocation of both MAP kinase isoforms in the 
nucleus of HeLa cells.  These authors did not possess  an 
isoform-specific antibody, thus they were unable to distin- 
guish  between  the  two  ubiquitously  expressed  isoforms 
p42  m~ and  p44  "~pk. Our present  study also confirms and 
extends the observations of Sanghera et al. (1992) and Seth 
et al.  (1992)  showing  respectively that  avian homolog of 
MAP  kinase  is  nuclearly  located  and  that  transfected 
p42  '~pk into cos-7 cells not only is nuclear but also able to 
phosphorylate Ser62 of the transactivation domain of c-myc. 
MAP kinases are activated rapidly by a  wide variety of 
agents which include mitogens, neurotransmitters, differen- 
tiating agents, phorbol esters, heat shock, etc. (Pelech et al., 
1992). Here we have demonstrated that among the agonists 
that are capable of inducing a mitogenic response in CCL39 
cells, only the strong mitogens such as c~-thrombin,  FGF, or 
serum that are known to elicit a persistent MAP kinase acti- 
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efficiently 1M4  m~ nuclear translocation.  Synergistic mito- 
gens like ot-thrombin/FGF for DNA replication also syner- 
gize for the number of nuclei scored positive for p44~  im- 
munostalning. Chen et al.  (1992) have shown that phorbol 
esters induce nuclear translocation of MAP kinases in the 
HeLa tumor cell line. In CCL39 cells, however, phorbol es- 
ters that activate only the first and transient peak of MAP ki- 
nase, are not mitogenic and do not induce p44  ~'~k nuclear 
translocation. Thus it is likely that this discrepancy between 
our results and theirs is due to a marked difference in the re- 
sponse of CCL39 and HeLa cells to phorbol esters. This ob- 
servation strengthens our previous findings that MAP ldnase 
activation appears to be essential to deliver the mitogenic re- 
sponse (Pages  et al.,  1993)  and we propose that nuclear 
transfer is critical for MAP kinase action. However this no- 
tion is not general since in dog thyrocytes the cAMP pathway 
that leads to mitogenicity does so without activating MAP 
kinases (Lamy et al.,  1993).  Nevertheless, we predict that 
the EGF-induced mitogenicity should require MAP kinase 
activation in these cells. 
Transfected p44  ~pk and p42  ma# showed marked accumu- 
lation in the nucleus of nonstimulated cells and in particular 
when overexpressed. Thus, one possibility is that overex- 
pression overwhelms the capacity of a putative cytoplasmic 
anchor to retain MAP kinases in the cytoplasm. Finally, the 
expression of MAP kinase-dead mutants yielded an unex- 
pected result. We found that the nuclear transfer as well as 
the retention in the nucleus were independent of the state of 
MAP kinase activity. This observation implicates that the 
nuclear transport is achieved irrespective of kinase phos- 
phorylation/activation. This is confirmed by the nuclear lo- 
calization of overexpressed wild type MAP kinases that are 
neither active nor phosphorylated in the GO state. The mech- 
anism of MAP kinase nuclear transfer is obscure since MAP 
kinases do not seem to possess any canonical nuclearization 
signal in their sequence. However it was possible to abolish 
the growth factor-stimulatable as well as constitutive transfer 
into  the  nucleus  by  removing  the  last  129  residues  of 
p44m~PL This approach will be refined to map the domains 
critical for nuclear transfer. 
A second aspect of the present study demonstrated for the 
first time that the MAP kinase activator, p45~m, remained 
cytoplasmic during the cell cycle regardless of its state of ac- 
tivation and even when overexpressed. Thus, unlike MAP ki- 
nases, IM5  "~#-~ appears to be totally excluded from the nu- 
cleus. This finding is rather intriguing if we accept that the 
upstream activator of p45  ~m, raf-1 also translocates to the 
nucleus in response to growth factors (Rapp et al.,  1988). 
Why is the entire protein kinase module not nuclear? An al- 
ternative interpretation is that raf-1, like MAP kinases exerts 
a specific function in the nucleus modulating transcription 
factors. In that context a cytoplasmic MAP kinase kinase ac- 
tivator, distinct of raf-1,  should exist. This is precisely the 
case since a 78-kD protein kinase capable to phosphorylate 
and  activate p45  "~m has just  been  characterized (Lange- 
Carter et al., 1993). This protein kinase referred to as MAP 
ldnase kinase kinase is the homolog ofbyr2 ofS. pombe. We 
predict that like p45  "~'a, this activator should have a cyto- 
plasmic localization. If this model is correct, how can the 
MAP kinases present in the nucleus remain active if their ac- 
tivator, p45~,  is excluded from the nucleus? One has to 
postulate that MAP kinases shuttle between the nucleus and 
the cytoplasm to stay continuously activated, or that phos- 
phatase activity is differentially regulated in the cytoplasm 
and the nucleus. Alternatively, a partial cotransfer to the nu- 
cleus of p45~  complexed with its substrate, MAP kinases 
could have easily escaped our technique of immunostaining. 
In summary, we previously demonstrated that MAP kinase 
activation is required for growth factor-stimulated cells to 
progress and enter S-phase. Here we have shown that MAP 
kinases specifically translocate to the nucleus and remain 
nuclear during the entire G1 period, a process, we believe, 
essential to induce gene expression. Future experiments will 
be designed to inhibit specifically MAP kinase nuclear trans- 
location, a mean that should lead to cell growth arrest. 
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